Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

January 20, 2027

Study Completion Date

April 27, 2027

Conditions
Hepatitis B
Interventions
DRUG

Bepirovirsen

Bepirovirsen will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (52)

220

RECRUITING

GSK Investigational Site, Banchiau Taipei

813

RECRUITING

GSK Investigational Site, Kaohsiung City

1023

RECRUITING

GSK Investigational Site, Buenos Aires

1459

RECRUITING

GSK Investigational Site, Reiger Park

2092

RECRUITING

GSK Investigational Site, Johannesburg

4052

RECRUITING

GSK Investigational Site, Durban

13003

RECRUITING

GSK Investigational Site, Marseille

14004

RECRUITING

GSK Investigational Site, Córdoba

16132

RECRUITING

GSK Investigational Site, Genova

20157

RECRUITING

GSK Investigational Site, Milan

20162

RECRUITING

GSK Investigational Site, Milan

21287

RECRUITING

GSK Investigational Site, Baltimore

28032

RECRUITING

GSK Investigational Site, Madrid

28040

RECRUITING

GSK Investigational Site, Madrid

28041

RECRUITING

GSK Investigational Site, Madrid

28046

RECRUITING

GSK Investigational Site, Madrid

32803

RECRUITING

GSK Investigational Site, Orlando

33409

RECRUITING

GSK Investigational Site, West Palm Beach

34295

RECRUITING

GSK Investigational Site, Montpellier

44093

RECRUITING

GSK Investigational Site, Nantes

50134

RECRUITING

GSK Investigational Site, Florence

55415

RECRUITING

GSK Investigational Site, Minneapolis

75012

RECRUITING

GSK Investigational Site, Paris

75018

RECRUITING

GSK Investigational Site, Paris

77000

RECRUITING

GSK Investigational Site, Melun

80131

RECRUITING

GSK Investigational Site, Napoli

93301

COMPLETED

GSK Investigational Site, Bakersfield

94115

RECRUITING

GSK Investigational Site, San Francisco

08844

RECRUITING

GSK Investigational Site, Hillsborough

C1427CEA

RECRUITING

GSK Investigational Site, Almagro

C1181ACI

RECRUITING

GSK Investigational Site, Buenos Aires

C1425AGC

RECRUITING

GSK Investigational Site, Buenos Aires

B1900AVG

RECRUITING

GSK Investigational Site, La Plata

S2002KDR

RECRUITING

GSK Investigational Site, Rosario

49060-010

RECRUITING

GSK Investigational Site, Aracaju

13034-685

RECRUITING

GSK Investigational Site, Campinas

80810-050

RECRUITING

GSK Investigational Site, Curitiba

69040-000

RECRUITING

GSK Investigational Site, Manaus

40110-060

RECRUITING

GSK Investigational Site, Salvador

04121-000

RECRUITING

GSK Investigational Site, São Paulo

K1H 8L6

RECRUITING

GSK Investigational Site, Ottawa

M5G 1K2

RECRUITING

GSK Investigational Site, Toronto

H2L 4P9

RECRUITING

GSK Investigational Site, Montreal

H4A 3J1

RECRUITING

GSK Investigational Site, Montreal

G1V 4G2

RECRUITING

GSK Investigational Site, Québec

00153

RECRUITING

GSK Investigational Site, Roma

07100

RECRUITING

GSK Investigational Site, Sassari

08036

RECRUITING

GSK Investigational Site, Barcelona

BS10 5NB

RECRUITING

GSK Investigational Site, Bristol Avon

E1 1BB

RECRUITING

GSK Investigational Site, London

NW3 2QG

RECRUITING

GSK Investigational Site, London

SE5 9RS

RECRUITING

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY